Florida Department of Agriculture and Consumer Services

12/16/2025 | Press release | Distributed by Public on 12/16/2025 10:54

Recall - ReBoost, ClearLife (Nasal spray, 0.68 fl oz) produced by MediNatura New Mexico Inc. - Product has been found to contain yeast/mold and microbial contamination with one[...]

Summary

Company Announcement Date: December 16, 2025 FDA Publish Date: December 16, 2025 Product Type: Drugs Reason for Announcement:
Recall Reason Description
Product has been found to contain yeast/mold and microbial contamination with one species identified as Achromobacter, at levels above specifications.
Company Name: MediNatura New Mexico Inc. Brand Name:
Brand Name(s)
ReBoost, ClearLife
Product Description:
Product Description
Nasal spray, 0.68 fl oz

Company Announcement

FOR IMMEDIATE RELEASE - December 16, 2025 - Albuquerque, New Mexico, MediNatura New Mexico, Inc. is voluntarily recalling all lots of ReBoost Nasal Spray to the consumer level. The product has been found to contain yeast/mold and microbial contamination with one species identified as Achromobacter, at levels above specifications. It is also recalling all lots of ClearLife Nasal Spray to the consumer level. The product has been found to contain microbial contamination that may be linked to Achromobacter at levels above specifications. This expansion has been initiated due to the company's further investigative efforts.

Risk Statement: There is a reasonable probability that adverse health consequences including life-threatening infections will occur with use of the product in the immuno-compromised population. To date, MediNatura has not received any reports of adverse events related to this recall.

ReBoost Nasal Spray is used as a homeopathic nasal spray to temporarily relieve nasal congestion, sinus headache and pressure, postnasal drip, sneezing, runny nose, and nasal itching and is packaged in a 20mL bottle which is further packaged in a white and yellow carton. The NDC number is 62795-4005-9 and the UPC# is 787647 10186 3. The recalled ReBoost product includes all lots within expiration to ensure consumer safety [Product with Expiration date of 12/2022 to 12/2025].

ClearLife Allergy Nasal Spray is used as a homeopathic nasal spray to temporarily relieve minor allergy symptoms such as sinus pressure, runny or itchy nose, nasal congestion, allergic rhinitis, sneezing, itchy or watery eyes, allergy-related headache, and itchy throat and skin. The product is packaged in a 20mL bottle which is further packaged in a white and green carton. The NDC number is 62795-4006-9 and the UPC# is 787647 10188 7. The recalled ClearLife product includes all lot numbers within expiration to ensure the safety of consumers [Product with Expiration date of 12/2022 to 12/2025].

The products can be identified by their bottle labels and cartons:

ReBoost and ClearLife were distributed nationwide via retail and internet sales(medinatura.com).

All customers should immediately discontinue using the products under recall. Customers who purchased the product directly from MediNatura New Mexico, Inc. should contact MediNatura New Mexico, Inc. at [email protected] to arrange for a refund. Consumers who purchased the product at retailers should return it to the place of purchase.

Consumers with questions regarding this recall can contact MediNatura New Mexico, Inc by phone (800-621-7644) or [email protected]; Monday-Friday, 8:00 AM to 5:00 PM MST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Original Recall

Company Contact Information

Consumers: (800) 621-7644 [email protected]

Product Photos

Florida Department of Agriculture and Consumer Services published this content on December 16, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on December 16, 2025 at 16:55 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]